Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
2021; Elsevier BV; Volume: 137; Issue: 23 Linguagem: Inglês
10.1182/blood.2021011568
ISSN1528-0020
AutoresYair Herishanu, Irit Avivi, Anat Aharon, Gabi Shefer, Shai Levi, Yotam Bronstein, M. Morales, Tomer Ziv, Yamit Shorer Arbel, Lydia Scarfò, Erel Joffe, Chava Perry, Paolo Ghia,
Tópico(s)Cancer Immunotherapy and Biomarkers
Referência(s)